Credit Capital Investments’s ResMed RMD Stock Holding History

Credit Capital Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,361	Closed	-$349K	–	62
2023 Q3	$349K	Buy	+2,361	New	+$427K	0.46%	43
2023 Q1	–	Sell	-1,000	Closed	-$208K	–	75
2022 Q4	$208K	Buy	+1,000	New	+$220K	0.3%	55

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Capital Investments's RMD Position: Q4 2023 in Review

Credit Capital Investments sold out of ResMed (RMD) in Q4 2023, closing a stake of 2,361 shares — an estimated $349K sold.

Credit Capital Investments first reported a position in RMD in Q4 2022 and held it in 2 quarters. The position peaked at $349K in Q3 2023. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

Credit Capital Investments reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
Credit Capital Investments sold 2,361 ResMed shares in Q4 2023, an estimated $349K.
Credit Capital Investments first reported a position in ResMed in Q4 2022 and held it in 2 quarters.
Credit Capital Investments's ResMed position peaked at $349K in Q3 2023.
688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Credit Capital Investments's 13F filing for Q4 2023, filed 14 Feb 2024.